Diversification opportunity assessment for large family group in MENA pharmaceutical sector
Background
A GCC-based family-owned conglomerate engaged Aranca to assess opportunity for pharmaceutical manufacturing in KSA, with a sales focus in the MENA region
Aranca Approach
Detailed analysis of the existing landscape, therapeutic area wise opportunity assessment, detailed business plan and route to market strategy
Results
Our analysis helped the client identify the market potential and develop the market entry strategy into the targeted segment within the pharmaceuticals sector in MENA
Ideate
Identify key industry parameters and metrics
Define framework for comparative analysis of business segments (by disease type) and locations to identify relevant opportunities
Desk Research
Detailed analysis of Pharmaceuticals sector in MENA: market size, trends, and regulatory framework
Identification of growth potential for different therapeutic areas
Expert Interviews
Discussion with ~20 industry experts and competitors across MENA region
Focus on operating model, revenue and cost drivers and challenges
Analysis
Shortlist the most attractive drugs for a deep dive feasibility and location analysis
Formulate the go-to-market strategy, with a key focus on target operating model and marketing channel
